RPCONE
CARM

Retirement Planning Company of New England’s Carisma Therapeutics CARM Stock Holding History

Retirement Planning Company of New England’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed – – 312
2021
Q4 		$0 Buy
+3
New +$60 ﹤0.01% 918

Other funds holding CARM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Retirement Planning Company of New England's CARM Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of Carisma Therapeutics (CARM) in Q1 2022, closing a stake of 3 shares.

Retirement Planning Company of New England first reported a position in CARM in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 84 funds tracked by Wall St. Rank hold CARM as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining Carisma Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 3 Carisma Therapeutics shares in Q1 2022.
  • Retirement Planning Company of New England first reported a position in Carisma Therapeutics in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's Carisma Therapeutics position peaked at $0 in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.